News - Biotechnology, Global

Filter

Current filters:

BiotechnologyGlobal

Popular Filters

1 to 25 of 84 results

inVentiv and ACRES partner to create a global research platform for clinical trials

inVentiv and ACRES partner to create a global research platform for clinical trials

11-07-2014

Two bodies are partnering to fast-track the development of a global system to support responsible conduct…

BiotechnologyClinical researchDrug developmentGlobalGreg KoskiinVentive HealthPharmaceuticalResearch

ICBA adopts antimicrobial resistance as an inaugural priority, proposed by BIA

ICBA adopts antimicrobial resistance as an inaugural priority, proposed by BIA

27-06-2014

At the inaugural meeting of the newly formed International Council of Biotech Associations (ICBA) which…

Antibiotics and Infectious diseasesBiotechnologyGlobalHealthcareResearch

Global biotechnology industry needs new paradigm for drug R&D

Global biotechnology industry needs new paradigm for drug R&D

24-06-2014

The global biotechnology industry rebounded strongly in 2013, with public companies achieving double-digit…

BiotechnologyFinancialGlobalResearch

Vertex licenses novel influenza treatment VX-787 to Janssen

Vertex licenses novel influenza treatment VX-787 to Janssen

18-06-2014

US biotech firm Vertex Pharmaceuticals has inked a deal with health care giant Johnson & Johnson subsidiary…

Anti-viralsBiotechnologyGlobalHealth Medical PharmaJanssenJohnson & JohnsonLicensingVertex PharmaceuticalsVX-787

Lucrative biosimilars space to erode biologics market from 2019

Lucrative biosimilars space to erode biologics market from 2019

11-06-2014

The increasing prevalence of biosimilars will have a noticeably negative impact on the biologics market…

BiosimilarsBiotechnologyGlobalMarkets & MarketingRegulation

Report shows rise in IPOs revive investments in pharma and biotech

Report shows rise in IPOs revive investments in pharma and biotech

29-05-2014

The heightened private equity and venture capital (PEVC) deal activity in the global health care industry…

BiotechnologyBusiness FinanceFinancialGlobalHealth Medical PharmaPharmaceuticalPharmaceutical industryPharmaceutical sciencesPrivate

Sustainability of sky-high M&A valuations will be the biggest question for 2014, says new report

12-03-2014

The cautious optimism of 2012 turned into a fully fledged biotech boom in 2013, marked by surging company…

BiotechnologyGlobalMergers & AcquisitionsPharmaceutical

Survey: Pharma CEOs on the importance of technology, demographics and innovation

Survey: Pharma CEOs on the importance of technology, demographics and innovation

07-02-2014

A global survey of chief executives has revealed the priorities and concerns of pharmaceutical and life…

BiotechnologyBoardroomGlobalMarkets & MarketingPharmaceutical

Gilead to offer hep C drug sofosbuvir at greatly-reduced price in developing countries

Gilead to offer hep C drug sofosbuvir at greatly-reduced price in developing countries

07-02-2014

US biotech Gilead Sciences has indicated it would charge $2,000 per 24 week treatment course for the…

Anti-viralsBiotechnologyGilead SciencesGlobalIndiaPricingsofosbuvirSovaldi

Modest growth forecast for global Crohn’s disease market

Modest growth forecast for global Crohn’s disease market

04-02-2014

The global Crohn’s disease (CD) market value is forecast to show modest growth, climbing from $3.2…

AbbVieBiotechnologyEntyvioGastro-intestinalsGlobalHumiraJohnson & JohnsonMarkets & MarketingPharmaceuticalRemicadeStelara InjectionTakeda Pharmaceuticals

Pharma M&A deals in 2013 down, but values marginally higher

Pharma M&A deals in 2013 down, but values marginally higher

13-01-2014

Merger and acquisition activity in the pharmaceutical, biotechnology and generic drugs sectors continued…

BiotechnologyGlobalMergers & AcquisitionsPharmaceutical

Nanomedicines market to reach $177.6 billion globally in 2019

08-01-2014

The global market for nanomedicine was valued at $78.54 billion in 2012 and is expected to reach a value…

BiotechnologyCardio-vascularGlobalMarkets & MarketingOncology

Emerging markets and patent cliffs create supply chain management issues for pharma, white paper warns

Emerging markets and patent cliffs create supply chain management issues for pharma, white paper warns

26-12-2013

A new white paper commissioned by logistics company DHL warns that global life sciences and health care…

BiotechnologyGlobalMarkets & MarketingPharmaceuticalProduction

Prothena inks deal with Roche, worth a potential $600 million

Prothena inks deal with Roche, worth a potential $600 million

12-12-2013

Biotech firm Prothena has entered into a worldwide collaboration with Swiss drug major Roche to develop…

BiotechnologyGlobalLicensingNeurologicalProthenaPRX002ResearchRoche

H1N1 virus market to be worth $273 million by 2018

22-10-2013

The H1N1 vaccines market has been forecast to decline in value over the next five years, reaching a value…

BiotechnologyFinancialGlobalHealthcareVaccines

Nanomedicine market to increase at a CAGR of 12.6%

04-09-2013

The global nanomedicine market has been forecast to increase at a compound annual growth rate (CAGR)…

BiotechnologyGlobalMarkets & MarketingPharmaceutical

New entrants to multiple sclerosis market will drive 10% pa growth through 2018

26-07-2013

The market for disease-modifying multiple sclerosis (MS) therapies will expand at an annual rate of 10%…

AbbVieAubagioBayerBiogen IdecBiotechnologydaclizumabGlobalLemtradaMarkets & MarketingNeurologicalocrelizumabPharmaceuticalRocheSanofiTecfidera

Ligand enters global license deal for women's health product

23-07-2013

Ligand Pharmaceuticals (Nasdaq: LGND) announces the signing of a global license agreement with recently-formed…

Azure BiotechBiotechnologyGloballasofoxifeneLicensingLigand PharmaceuticalsPfizerPharmaceuticalWomen's Health

Pace of drug approvals to moderate for global pharma companies, says Fitch Ratings

21-05-2013

Global pharmaceutical novel drug approvals will moderate in 2013 due to the exceptional research success…

BiotechnologyGlobalNorth AmericaPharmaceuticalRegulationResearch

Cancer treatments "unaffordable" and will drive rapid transition to generics and market decline, says GlobalData

10-05-2013

The rising prices of new cancer drugs are resulting in an increasing cost burden for patients and health…

BiotechnologyGenericsGlobalMarkets & MarketingOncologyPharmaceuticalPricing

Global biosimilar drug revenues will reach $2,445 million in 2013, says Visiongain

08-05-2013

The world market for biosimilar drugs will be worth $2,445 million in 2013, growing by more than 20%…

BiotechnologyCellTrionGenericsGlobalHospiraMarkets & MarketingSandoz

Europe falling behind USA and China as attractive for life sciences sector

22-04-2013

Intellectual property specialists Marks & Clerk's latest Life Sciences Report unveils the changing landscape…

BiotechnologyFinancialGlobalPatentsPharmaceuticalRegulationResearch

Pfenex and Agila Biotech set up JV to develop biosimilars

16-04-2013

US biotech firm Pfenex Inc. and Agila Biotech, a subsidiary of Indian drugmaker Strides Arcolab (BO:…

Agila BiotechBayerBetaferonBetaseronBiotechnologyGenericsGlobalNeurologicalPfenexProductionResearchStrides Arcolab

1 to 25 of 84 results

Back to top